Origins and spread of pfdhfr mutant alleles in Plasmodium falciparum

Acta Tropica

Volumn 114, Issue 3, 2010, Pages 166-170

  Mita, Toshihiro ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Dhfr; Evolution; Malaria; Resistance; Spread; Sulfadoxine pyrimethamine

Indexed keywords

ARTESUNATE; FANSIDAR; PYRIMETHAMINE; SULFADOXINE;

ALLELE; ENZYME; GEOGRAPHICAL DISTRIBUTION; MALARIA; MUTATION; PARASITE; PROTOZOAN;

ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG MECHANISM; HUMAN; IN VITRO STUDY; MALARIA FALCIPARUM; MICROSATELLITE MARKER; MOLECULAR EVOLUTION; MONOTHERAPY; MUTANT; NONHUMAN; PLASMODIUM FALCIPARUM; SINGLE DRUG DOSE;

AFRICA; ALLELES; ANTIMALARIALS; DIHYDROPTEROATE SYNTHASE; DRUG RESISTANCE; EVOLUTION, MOLECULAR; HUMANS; MALARIA, FALCIPARUM; MICROSATELLITE REPEATS; MOLECULAR EPIDEMIOLOGY; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; PYRIMETHAMINE; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE;

AFRICA;

PLASMODIUM FALCIPARUM;

EID: 77950033492     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2009.07.008     Document Type: Article

References (62)

1. Anderson T.J., Haubold B., Williams J.T., Estrada-Franco J.G., Richardson L., Mollinedo R., Bockarie M., Mokili J., Mharakurwa S., French N., Whitworth J., Velez I.D., Brockman A.H., Nosten F., Ferreira M.U., Day K.P. Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol. Biol. Evol. 2000, 17:1467-1482.
2. Anderson T.J., Su X.Z., Bockarie M., Lagog M., Day K.P. Twelve microsatellite markers for characterization of Plasmodium falciparum from finger-prick blood samples. Parasitology 1999, 119(Pt 2):113-125.
3. Archibald H.M. Preliminary field trials on a new schizonticide. Br. Med. J. 1951, 2:821-823.
4. Basco L.K., Eldin de Pecoulas P., Wilson C.M., Le Bras J., Mazabraud A. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol. Biochem. Parasitol. 1995, 69:135-138.
5. Bjorkman A., Phillips-Howard P.A. The epidemiology of drug-resistant malaria. Trans. R. Soc. Trop. Med. Hyg. 1990, 84:177-180.
6. Black F., Bygbjerg I., Effersoe P., Gomme G., Jepsen S., Jensen G.A. Fansidar resistant falciparum malaria acquired in South East Asia. Trans. R. Soc. Trop. Med. Hyg. 1981, 75:715-716.
7. Brooks D.R., Wang P., Read M., Watkins W.M., Sims P.F., Hyde J.E. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur. J. Biochem. 1994, 224:397-405.
8. Burgess R.W., Young M.D. The development of pyrimethamine resistance by Plasmodium falciparum. Bull. World Health Org. 1959, 20:37-46.
9. Bzik D.J., Li W.B., Horii T., Inselburg J. Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:8360-8364.
10. Certain L.K., Briceno M., Kiara S.M., Nzila A.M., Watkins W.M., Sibley C.H. Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987-2006. J. Infect. Dis. 2008, 197:1743-1751.
11. Clyde D.F., Shute G.T. Resistance of East African varieties of Plasmodium falciparum to pyrimethamine. Trans. R. Soc. Trop. Med. Hyg. 1954, 48:495-500.
12. Clyde D.F., Shute G.T. Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals. Trans. R. Soc. Trop. Med. Hyg. 1957, 51:505-513.
13. Cortese J.F., Caraballo A., Contreras C.E., Plowe C.V. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J. Infect. Dis. 2002, 186:999-1006.
14. Cortese J.F., Plowe C.V. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast. Mol. Biochem. Parasitol. 1998, 94:205-214.
15. Covell G., Shute P.G., Maryon M. Pyrimethamine (daraprim) as a prophylactic agent against a West African strain of P. falciparum. Br. Med. J. 1953, 1:1081-1082.
16. Cox-Singh J., Zakaria R., Abdullah M.S., Rahman H.A., Nagappan S., Singh B. Short report: differences in dihydrofolate reductase but not dihydropteroate synthase alleles in Plasmodium falciparum isolates from geographically distinct areas in Malaysia. Am. J. Trop. Med. Hyg. 2001, 64:28-31.
17. Doberstyn E.B., Hall A.P., Vetvutanapibul K., Sonkon P. Single-dose therapy of falciparum malaria using pyrimethamine in combination with diformyldapsone or sulfadoxine. Am. J. Trop. Med. Hyg. 1976, 25:14-19.
18. Espinal C.A., Cortes G.T., Guerra P., Arias A.E. Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia. Am. J. Trop. Med. Hyg. 1985, 34:675-680.
19. Ferraroni J.J., Hayes J. Drug-resistant falciparum malaria among the Mayongong Indians in the Brazilian Amazon. Am. J. Trop. Med. Hyg. 1979, 28:909-911.
20. Feuillat F., Parent M., Peeters E.M., Vincke I.H. Recent progress in the fight against malaria in Katanga. Ann. Soc. Belg. Med. Trop. (1920). 1953, 33:621-674.
21. Foote S.J., Galatis D., Cowman A.F. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:3014-3017.
22. Gabaldon A., Guerrero L. An attempt to eradicate malaria by the weekly administration of pyrimethamine in areas of out-of-doors transmission in Venezuela. Am. J. Trop. Med. Hyg. 1959, 8:433-439.
23. Greenberg A.E., Ntumbanzondo M., Ntula N., Mawa L., Howell J., Davachi F. Hospital-based surveillance of malaria-related paediatric morbidity and mortality in Kinshasa, Zaire. Bull. World Health Org. 1989, 67:189-196.
24. Harinasuta T., Viravan C., Reid H.A. Sulphormethoxine in chloroquine-resistant falciparum malaria in Thailand. Lancet 1967, 1:1117-1119.
25. Hurly M.G. Administration of pyrimethamine with folic acid and folinic acids in human malaria. Trans. R. Soc. Trop. Med. Hyg. 1959, 53:410-411.
26. Hurly M.G. Potentiation of pyrimethamine by sulphadiazine in human malaria. Trans. R. Soc. Trop. Med. Hyg. 1959, 53:412-413.
27. Jones S.A. Resistance of P. falciparum and P. malariae to pyrimethamine (daraprim) following mass treatment with this drug: a preliminary note. East Afr. Med. J. 1954, 31:47-49.
28. Jones S.A. Mass treatment with pyrimethamine: a study of resistance and cross resistance resulting from a field trial in the hyperendemic malarious area of Makueni, Kenya, September 1952-September 1953. Trans. R. Soc. Trop. Med. Hyg. 1958, 52:547-561.
29. Khim N., Bouchier C., Ekala M.T., Incardona S., Lim P., Legrand E., Jambou R., Doung S., Puijalon O.M., Fandeur T. Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia. Antimicrob. Agents Chemother. 2005, 49:3147-3152.
30. Laing A.B. Hospital and field traials of sulformethoxine with pyrimethamine against Malaysian strains of Plasmodium falciparum and P. vivax. Med. J. Malaya 1968, 23:5-19.
31. Maiga O., Djimde A.A., Hubert V., Renard E., Aubouy A., Kironde F., Nsimba B., Koram K., Doumbo O.K., Le Bras J., Clain J. A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa. J. Infect. Dis. 2007, 196:165-172.
32. Marsh K. Malaria disaster in Africa. Lancet 1998, 352:924.
33. Mberu E.K., Mosobo M.K., Nzila A.M., Kokwaro G.O., Sibley C.H., Watkins W.M. The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya. Am. J. Trop. Med. Hyg. 2000, 62:396-401.
34. McCollum A.M., Basco L.K., Tahar R., Udhayakumar V., Escalante A.A. Hitchhiking and selective sweeps of Plasmodium falciparum sulfadoxine and pyrimethamine resistance alleles in a population from central Africa. Antimicrob. Agents Chemother. 2008, 52:4089-4097.
35. McCollum A.M., Mueller K., Villegas L., Udhayakumar V., Escalante A.A. Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America. Antimicrob. Agents Chemother. 2007, 51:2085-2091.
36. McCollum A.M., Poe A.C., Hamel M., Huber C., Zhou Z., Shi Y.P., Ouma P., Vulule J., Bloland P., Slutsker L., Barnwell J.W., Udhayakumar V., Escalante A.A. Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J. Infect. Dis. 2006, 194:189-197.
37. Meuwissen J.H. Resistance of Plasmodium falciparum to pyrimethamine and proguanil in Netherlands New Guinea. Am. J. Trop. Med. Hyg. 1961, 10:135-139.
38. Mita T., Tanabe K., Takahashi N., Culleton R., Ndounga M., Dzodzomenyo M., Akhwale W.S., Kaneko A., Kobayakawa T. Indigenous evolution of Plasmodium falciparum pyrimethamine resistance multiple times in Africa. J. Antimicrob. Chemother. 2009, 63:252-255.
39. Mita T., Tanabe K., Takahashi N., Tsukahara T., Eto H., Dysoley L., Ohmae H., Kita K., Krudsood S., Looareesuwan S., Kaneko A., Bjorkman A., Kobayakawa T. Independent evolution of pyrimethamine resistance in Plasmodium falciparum isolates in Melanesia. Antimicrob. Agents Chemother. 2007, 51:1071-1077.
40. Mockenhaupt F.P., Teun Bousema J., Eggelte T.A., Schreiber J., Ehrhardt S., Wassilew N., Otchwemah R.N., Sauerwein R.W., Bienzle U. Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana. Trop. Med. Int. Health 2005, 10:901-908.
41. Nair S., Williams J.T., Brockman A., Paiphun L., Mayxay M., Newton P.N., Guthmann J.P., Smithuis F.M., Hien T.T., White N.J., Nosten F., Anderson T.J. A selective sweep driven by pyrimethamine treatment in Southeast Asian malaria parasites. Mol. Biol. Evol. 2003, 20:1526-1536.
42. Nash D., Nair S., Mayxay M., Newton P.N., Guthmann J.P., Nosten F., Anderson T.J. Selection strength and hitchhiking around two anti-malarial resistance genes. Proc. Biol. Sci. 2005, 272:1153-1161.
43. Nosten F., White N.J. Artemisinin-based combination treatment of falciparum malaria. Am. J. Trop. Med. Hyg. 2007, 77:181-192.
44. Nurse G.T. Fansidar-resistant falciparum malaria in Papua New Guinea. Lancet 1981, 1:36-37.
45. Nzila-Mounda A., Mberu E.K., Sibley C.H., Plowe C.V., Winstanley P.A., Watkins W.M. Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain. Antimicrob. Agents Chemother. 1998, 42:164-169.
46. Omar S.A., Adagu I.S., Warhurst D.C. Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure?. Trans. R. Soc. Trop. Med. Hyg. 2001, 95:315-319.
47. Pearce R., Malisa A., Kachur S.P., Barnes K., Sharp B., Roper C. Reduced variation around drug-resistant dhfr alleles in African Plasmodium falciparum. Mol. Biol. Evol. 2005, 22:1834-1844.
48. Pearce R.J., Pota H., Evehe M.S., Ba el H., Mombo-Ngoma G., Malisa A.L., Ord R., Inojosa W., Matondo A., Diallo D.A., Mbacham W., van den Broek I.V., Swarthout T.D., Getachew A., Dejene S., Grobusch M.P., Njie F., Dunyo S., Kweku M., Owusu-Agyei S., Chandramohan D., Bonnet M., Guthmann J.P., Clarke S., Barnes K.I., Streat E., Katokele S.T., Uusiku P., Agboghoroma C.O., Elegba O.Y., Cisse B., IE A.E., Giha H.A., Kachur S.P., Lynch C., Rwakimari J.B., Chanda P., Hawela M., Sharp B., Naidoo I., Roper C. Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med. 2009, 6. e1000055.
49. Peterson D.S., Walliker D., Wellems T.E. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:9114-9118.
50. Pinichpongse S., Doberstyn E.B., Cullen J.R., Yisunsri L., Thongsombun Y., Thimasarn K. An evaluation of five regimens for the outpatient therapy of falciparum malaria in Thailand 1980-81. Bull. World Health Org. 1982, 60:907-912.
51. Primmer C.R., Saino N., Moller A.P., Ellegren H. Directional evolution in germline microsatellite mutations. Nat. Genet. 1996, 13:391-393.
52. Roper C., Pearce R., Bredenkamp B., Gumede J., Drakeley C., Mosha F., Chandramohan D., Sharp B. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet 2003, 361:1174-1181.
53. Roper C., Pearce R., Nair S., Sharp B., Nosten F., Anderson T. Intercontinental spread of pyrimethamine-resistant malaria. Science 2004, 305:1124.
54. Rumans L.W., Dennis D.T., Atmosoedjono S. Fansidar resistant falciparum malaria in Indonesia. Lancet 1979, 2:580-581.
55. Su X., Wellems T.E. Toward a high-resolution Plasmodium falciparum linkage map: polymorphic markers from hundreds of simple sequence repeats. Genomics 1996, 33:430-444.
56. Toma H., Imada Y., Vannachone B., Miyagi M., Kobayashi J., Uechi G., Pethuvang R., Manivong K., Phompida S., Sato Y. A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR. Southeast Asian J. Trop. Med. Public Health 2005, 36:602-604.
57. Triglia T., Cowman A.F. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:7149-7153.
58. Triglia T., Menting J.G., Wilson C., Cowman A.F. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:13944-13949.
59. Vincke I.H. Preliminary note on medical prophylaxis with deraprim in rural areas. Ann. Soc. Belg. Med. Trop. (1920). 1952, 32:91-99.
60. Watkins W.M., Mberu E.K., Winstanley P.A., Plowe C.V. More on 'the efficacy of antifolate antimalarial combinations in Africa'. Parasitol. Today 1999, 15:131-132.
61. Wongsrichanalai C., Pickard A.L., Wernsdorfer W.H., Meshnick S.R. Epidemiology of drug-resistant malaria. Lancet Infect. Dis. 2002, 2:209-218.
62. Zhou Z., Griffing S.M., de Oliveira A.M., McCollum A.M., Quezada W.M., Arrospide N., Escalante A.A., Udhayakumar V. Decline in sulfadoxine-pyrimethamine-resistant alleles after change in drug policy in the Amazon region of Peru. Antimicrob. Agents Chemother. 2008, 52:739-741.